target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id tyrosine kinase with immunoglobulin like and EGF like domains 1,1841,P35590,Human,compound R-16 [PMID: 21967808],8213,,56597775,CNC(=O)c1cccc(c1Nc1nc(ncc1Cl)Nc1ccc2c(c1)NC(=O)[C@@H](CC2(C)C)NC(=O)N1CCCC1)F,"InChI=1S/C29H32ClFN8O3/c1-29(2)14-22(36-28(42)39-11-4-5-12-39)26(41)35-21-13-16(9-10-18(21)29)34-27-33-15-19(30)24(38-27)37-23-17(25(40)32-3)7-6-8-20(23)31/h6-10,13,15,22H,4-5,11-12,14H2,1-3H3,(H,32,40)(H,35,41)(H,36,42)(H2,33,34,37,38)/t22-/m1/s1",HGSNUBHWAMMKIR-JOCHJYFZSA-N,Inhibitor,Inhibition,,,,,,,,,,,,,=,Measured as % inhibition using 1μM compound.,,,21967808, tyrosine kinase with immunoglobulin like and EGF like domains 1,1841,P35590,Human,merestinib,9841,,44603533,Fc1ccc(cc1)n1c(C)ccc(c1=O)C(=O)Nc1ccc(c(c1)F)Oc1cc2cnn(c2cc1c1c[nH]nc1)C,"InChI=1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39)",QHADVLVFMKEIIP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKd,,9.05,,Kd,,0.9,,=,Binding constant assessed by KINOMEScan assay.,,,23275061, tyrosine kinase with immunoglobulin like and EGF like domains 1,1841,P35590,Human,BIIB091,11791,,135355941,O=C(c1cn(C(C)(C)C)nn1)N[C@H]1c2ccc(c3ccnc(Nc4cn(C)nc4)n3)cc2CN(C2COC2)CC1,"InChI=1S/C28H34N10O2/c1-28(2,3)38-15-25(34-35-38)26(39)32-24-8-10-37(21-16-40-17-21)13-19-11-18(5-6-22(19)24)23-7-9-29-27(33-23)31-20-12-30-36(4)14-20/h5-7,9,11-12,14-15,21,24H,8,10,13,16-17H2,1-4H3,(H,32,39)(H,29,31,33)/t24-/m1/s1",JSAQBOQCZJHWMA-XMMPIXPASA-N,Inhibitor,Inhibition,,,,,pKd,,7.4,,Kd,,40.0,,=,,,,34734694, tyrosine kinase with immunoglobulin like and EGF like domains 1,1841,P35590,Human,"compound 6li [Chan et al., 2022]",12249,,139533572,COc1c(OCCCN2CCOCC2)cc2nccc(Oc3c(F)cc(Nc4nn(C)cc4C(=O)NC4CCCCC4)cc3)c2c1,"InChI=1S/C34H41FN6O5/c1-40-22-26(34(42)38-23-7-4-3-5-8-23)33(39-40)37-24-9-10-30(27(35)19-24)46-29-11-12-36-28-21-32(31(43-2)20-25(28)29)45-16-6-13-41-14-17-44-18-15-41/h9-12,19-23H,3-8,13-18H2,1-2H3,(H,37,39)(H,38,42)",QBRQTJMZEYORSP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKd,,9.13,,Kd,,0.74,,=,,,,,